Skip to content

Contribution of Hypnosis to Anxiety and Pain in Brachytherapy Patients

Randomized Trial Comparing the Hypnosis Versus Standard Care of Anxiety and Pain in Patients With Brachytherapy

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03755895
Acronym
HYCUDES
Enrollment
68
Registered
2018-11-28
Start date
2019-11-02
Completion date
2022-05-25
Last updated
2026-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brachytherapy, Cancer

Keywords

Cancer, hypnosis, care management

Brief summary

Formal hypnosis is a non-drug technique known to decrease anxiety and pain during the preoperative procedure. In brachytherapy, the practice of hypnosis has been shown to be feasible and beneficial for patients treated for prostate cancer The goal of the study is to demonstrate the added value of hypnosis during a brachytherapy detachment by improving the comfort of the patient. The investigators want to evaluate the contribution of hypnosis during brachytherapy detachment by quantifying the anxiety and pain felt by the patient during the procedure.

Interventions

OTHERformal hypnosis

patients will have brachytherapy detachment under Kalinox and formal hypnosis

patients will have brachytherapy detachment under Kalinox

Sponsors

Institut de Cancérologie de Lorraine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients ≥ 18 and ≤ 80 years * Patients expected to benefit a brachytherapy detachment Under KALINOX® for one of the types of applications described below: * Deep interstitial application: anal canal, vagina, vulva * Gynecological application: mold, Utrecht® system or Venezia® system * Ability to provide written informed consent * Patients affiliated to the social security system

Exclusion criteria

* Minor and patients over 80 years old * Patients with major hearing loss * Patients who had recent ocular surgery with oculiare gas injection. * Patients suffering from psychotic disorders, and dementias. * Patients who do not understand the French language * Patients under guardianship or deprived of liberty * Patients with a contraindication to the administration of KALINOX®

Design outcomes

Primary

MeasureTime frameDescription
Anxiety evaluation1dayThe patient's anxiety will be assessed using the State-Trait Anxiety Inventory scale ("state of anxiety") before premedication (in the bedroom) and immediately after the brachytherapy detachment (in the examination room) during brachytherapy detachment using two care management: standard care versus standard care with formal hypnosis. The State-Trait Anxiety Inventory (STAI) is a commonly used measure of trait and state anxiety (Spielberger et al, 1983). The scale include 20 items. Higher scores indicate greater anxiety

Secondary

MeasureTime frameDescription
Pain evaluation: numeric scale1 dayPain will be evaluated by a numeric scale before premedication (in the room), just before and just after the brachytherapy detachment (in the examination room). Patient inform their level of pain from 0 to 10 (11 point scale) with the understanding that 0 is equal to no pain and 10 is equal to worst possible pain
Anxiety evaluation1 dayAnxiety will be evaluated by a numeric scale just before and just after the brachytherapy detachment. Patient inform their level of anxiety from 0 to 10 (11 point scale) with the understanding that 0 is equal to no anxiety and 10 is equal to worst possible anxiety
Patient's perception of the care1dayThe patient's perception of the care will be evaluated by a semi-directive phone interview conducted by the medical staff between day 3 and day 5 after the brachytherapy detachment
Time of brachytherapy detachment1dayThe time of brachytherapy detachment will be noted from the entrance to the patient's examination room until the end of the brachytherapy detachment
Realization of the brachytherapy detachment1dayThe ease of realization of the brachytherapy detachment and the comfort of the medical staff will be evaluated by an numeric scale at the end of the care and by a self-survey

Countries

France

Contacts

PRINCIPAL_INVESTIGATORSophie RENARD, Md

Institut de Cancérologie de Lorraine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 2, 2026